Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-02-12 @ 3:01 AM
Study NCT ID:
NCT02040857
Status:
COMPLETED
Last Update Posted:
2025-04-29
First Post:
2014-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
None
Primary Completion Date:
2018-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-13
First Submit QC Date:
None
Study First Post Date:
2014-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-30
Results First Submit QC Date:
None
Results First Post Date:
2020-12-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-23
Last Update Post Date:
2025-04-29
Last Update Post Date Type:
ACTUAL